1. Home
  2. ELTX vs HLP Comparison

ELTX vs HLP Comparison

Compare ELTX & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • HLP
  • Stock Information
  • Founded
  • ELTX 2011
  • HLP 2021
  • Country
  • ELTX United States
  • HLP China
  • Employees
  • ELTX N/A
  • HLP N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • HLP Industrial Machinery/Components
  • Sector
  • ELTX Health Care
  • HLP Industrials
  • Exchange
  • ELTX Nasdaq
  • HLP Nasdaq
  • Market Cap
  • ELTX 121.7M
  • HLP 102.1M
  • IPO Year
  • ELTX N/A
  • HLP 2023
  • Fundamental
  • Price
  • ELTX $10.05
  • HLP $1.49
  • Analyst Decision
  • ELTX Strong Buy
  • HLP
  • Analyst Count
  • ELTX 2
  • HLP 0
  • Target Price
  • ELTX $11.00
  • HLP N/A
  • AVG Volume (30 Days)
  • ELTX 68.1K
  • HLP 313.4K
  • Earning Date
  • ELTX 11-12-2025
  • HLP 09-19-2025
  • Dividend Yield
  • ELTX N/A
  • HLP N/A
  • EPS Growth
  • ELTX N/A
  • HLP N/A
  • EPS
  • ELTX N/A
  • HLP 0.02
  • Revenue
  • ELTX N/A
  • HLP $16,731,357.00
  • Revenue This Year
  • ELTX N/A
  • HLP N/A
  • Revenue Next Year
  • ELTX N/A
  • HLP N/A
  • P/E Ratio
  • ELTX N/A
  • HLP $69.15
  • Revenue Growth
  • ELTX N/A
  • HLP 19.13
  • 52 Week Low
  • ELTX $4.05
  • HLP $0.61
  • 52 Week High
  • ELTX $12.62
  • HLP $1.82
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 39.00
  • HLP 62.45
  • Support Level
  • ELTX $10.37
  • HLP $1.34
  • Resistance Level
  • ELTX $10.73
  • HLP $1.55
  • Average True Range (ATR)
  • ELTX 0.51
  • HLP 0.19
  • MACD
  • ELTX -0.09
  • HLP -0.01
  • Stochastic Oscillator
  • ELTX 9.49
  • HLP 64.62

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About HLP Hongli Group Inc.

Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.

Share on Social Networks: